Mediwound
NASDAQ: MDWDYavne · Israel corporation · 5 known investors
MediWound is a biotechnology company developing enzymatic treatments that selectively remove eschar tissue while preserving healthy tissue for burns and chronic wounds. Its products include NexoBrid, an approved therapy for severe thermal burns, and EscharEx, a candidate for debridement of chronic and hard-to-heal wounds, serving hospitalized and wound care patients worldwide.
BiotechHealthtechMedical Devices
Founders & leadership
BG
Boaz Gur-LavieChief Financial Officer
SM
Sharon MalkaExecutive
EK
Ety KlingerNamed on SEC filing
TP
Tzvi PalashNamed on SEC filing
AS
Assaf SegalNamed on SEC filing
SK
Sharon KochanNamed on SEC filing
DF
David FoxNamed on SEC filing
Board
OG
Ofer GonenBoard director
VR
Vickie R. DriverBoard director
NM
Nissim MashiachBoard director
ST
Stephen T. WillsBoard director
N(
Nachum (Homi) ShamirBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$30.5M disclosed across 2 rounds · 2022
▶$17.2MraisedOct 2022 · 10 investors · PharmaceuticalsRule 506(b)
▶$17.2MraisedOct 2022 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Yaron MeyerExecutive Officer
- Tzvi PalashExecutive Officer
- Vickie R. DriverDirector
- Nachum (Homi) ShamirDirector
- Sharon MalkaDirector
- Boaz Gur-LavieExecutive Officer
- Stephen T. WillsDirector
- Ety KlingerExecutive Officer, Director
- Assaf SegalDirector
- Ofer GonenExecutive Officer
- Lior RosenbergExecutive Officer
- Nissim MashiachDirector
- David FoxDirector
- Sharon KochanDirector
- Offering amount
- $17.2M
- Amount sold
- $17.2M
- Sales commissions
- $981.7K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Sep 2022
- Incorporated
- Corporation, Israel
- Federal exemptions
- 06b
▶$13.3MraisedOct 2022 · 13 investors · PharmaceuticalsRule 506(b)
▶$13.3MraisedOct 2022 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ety KlingerExecutive Officer, Director
- Ofer GonenExecutive Officer
- Boaz Gur-LavieExecutive Officer
- Sharon MalkaDirector
- Vickie R. DriverDirector
- Tzvi PalashExecutive Officer
- Nissim MashiachDirector
- Stephen T. WillsDirector
- Assaf SegalDirector
- Nachum (Homi) ShamirDirector
- Sharon KochanDirector
- David FoxDirector
- Yaron MeyerExecutive Officer
- Lior RosenbergExecutive Officer
- Offering amount
- $13.3M
- Amount sold
- $13.3M
- Sales commissions
- $928K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Sep 2022
- Incorporated
- Corporation, Israel
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapNatrox20 shared keywordsAdvanced wound care therapy delivering continuous topical oxygen to accelerate healing.
Vendelux20 shared keywords
Smith+Nephew17 shared keywordsSmith+Nephew is a medical technology company that develops products for the repair, regeneration and replacement of soft and hard tissue, operating through three business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It serves healthcare professionals and surgeons with implants, robotics-assisted surgical systems, arthroscopic technologies and wound care products across roughly 100 countries.
Companies competing with Mediwound for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Mediwound do?
- MediWound is a biotechnology company developing enzymatic treatments that selectively remove eschar tissue while preserving healthy tissue for burns and chronic wounds. Its products include NexoBrid, an approved therapy for severe thermal burns, and EscharEx, a candidate for debridement of chronic and hard-to-heal wounds, serving hospitalized and wound care patients worldwide.
- Who are Mediwound's investors?
- Mediwound's investors include Clal Biotechnology Industries, Deep Insight, Gandyr Investments, Israel Biotech Fund, New Era Capital Partners.
- How much funding has Mediwound raised?
- Mediwound has disclosed $30.5M raised across 2 rounds.
- Where is Mediwound headquartered?
- Mediwound is headquartered in Yavne.